Discovery of new potent protein arginine methyltransferase 5 (PRMT5) inhibitors by assembly of key pharmacophores from known inhibitors
文献类型：期刊论文
| 作者 | Zhu, Kongkai1,2; Song, Jia-Li1; Tao, Hong-Rui1; Cheng, Zhi-Qiang1; Jiang, Cheng-Shi1; Zhang, Hua1 |
| 刊名 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
 |
| 出版日期 | 2018-12-15 |
| 卷号 | 28期号:23-24页码:3693-3699 |
| ISSN号 | 0960-894X |
| 关键词 | Pharmacophore combination Isoquinoline PRMT5 inhibitor Molecular docking Molecular dynamics simulation |
| DOI | 10.1016/j.bmcl.2018.10.026 |
| 文献子类 | Article |
| 英文摘要 | Protein arginine methyltransferase 5 (PRMT5) is an epigenetics related enzyme that has been validated as a promising therapeutic target for human cancer. Up to now, two small molecule PRMT5 inhibitors has been put into phase I clinical trial. In the present study, a series of candidate molecules were designed by combining key pharmacophores of formerly reported PRMT5 inhibitors. The in vitro PRMT5 inhibitory testing of compound 4b14 revealed an IC50 of 2.71 mu M, exhibiting high selectivity over PRMT1 and PRMT4 (> 70-fold selective). As expected, 4b14 exhibited potent anti-proliferative activity against a panel of leukemia and lymphoma cells, including MV4-11, Pfeiffer, SU-DHL-4 and KARPAS-422. Besides, 4b14 showed significant cell cycle arrest and apoptosis-inducing effects, as well as reduced the cellular symmetric arginine dimethylation level of SmD3 protein. Finally, affinity profiling analysis indicated that hydrophobic interactions, pi-pi stacking and cation-pi actions made the major contributions to the overall binding affinity. This scaffold provides a new chemical template for further development of better lead compounds targeting PRMT5. |
| WOS关键词 | SELECTIVE INHIBITOR ; IDENTIFICATION ; METHYLATION ; GROWTH |
| 资助项目 | National Natural Science Foundation of China[81803438] ; National Natural Science Foundation of China[21672082] ; Shandong Provincial Natural Science Foundation[ZR2017BH038] ; Shandong Provincial Natural Science Foundation[JQ201721] ; Shandong Key Development Project[2016GSF201209] ; Young Taishan Scholars Program[tsqn20161037] ; Shandong Talents Team Cultivation Plan of University Preponderant Discipline[10027] ; Programs Foundation of University of Jinan[160100202] |
| WOS研究方向 | Pharmacology & Pharmacy ; Chemistry |
| 语种 | 英语 |
| 出版者 | PERGAMON-ELSEVIER SCIENCE LTD |
| WOS记录号 | WOS:000453232500022 |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/279466]  |
| 专题 | 药物发现与设计中心 |
| 通讯作者 | Jiang, Cheng-Shi; Zhang, Hua |
| 作者单位 | 1.Univ Jinan, Sch Biol Sci & Technol, Jinan 250022, Shandong, Peoples R China; 2.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China |
| 推荐引用方式 GB/T 7714 | Zhu, Kongkai,Song, Jia-Li,Tao, Hong-Rui,et al. Discovery of new potent protein arginine methyltransferase 5 (PRMT5) inhibitors by assembly of key pharmacophores from known inhibitors[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,2018,28(23-24):3693-3699. |
| APA | Zhu, Kongkai,Song, Jia-Li,Tao, Hong-Rui,Cheng, Zhi-Qiang,Jiang, Cheng-Shi,&Zhang, Hua.(2018).Discovery of new potent protein arginine methyltransferase 5 (PRMT5) inhibitors by assembly of key pharmacophores from known inhibitors.BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,28(23-24),3693-3699. |
| MLA | Zhu, Kongkai,et al."Discovery of new potent protein arginine methyltransferase 5 (PRMT5) inhibitors by assembly of key pharmacophores from known inhibitors".BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 28.23-24(2018):3693-3699. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。